Carotenoids inhibit DNA synthesis in human aortic smooth muscle cells  by Carpenter, Keri L.H et al.
Carotenoids inhibit DNA synthesis in human aortic smooth muscle cells
Keri L.H. Carpenter*, Simon J. Hardwick, Valentina Albarani, Malcolm J. Mitchinson
University of Cambridge, Department of Pathology, Tennis Court Road, Cambridge CB2 1QP, UK
Received 20 January 1999; received in revised form 9 February 1999
Abstract Quiescent, serum-starved human aortic smooth mus-
cle cells were restimulated with 20% foetal calf serum in
Dulbecco’s modified Eagle medium, in the presence and absence
of L-carotene, canthaxanthin, zeaxanthin, lycopene, lutein or L-
cryptoxanthin, at final concentrations up to 23 WM. Concentra-
tion-dependent inhibition of DNA synthesis, measured by
[methyl-3H]thymidine incorporation, was observed for the
carotenoids, except for canthaxanthin and lutein which had no
effect. Lycopene was the most potent of the carotenoids tested.
The results suggest that antiproliferative effects of dietary
carotenoids might be of significance in vivo.
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1. Introduction
Carotenoids are plant pigments absorbed from fruits and
vegetables in the diet. Epidemiological studies have shown
associations between diets rich in fruits and vegetables and
reduced risks of cancer, cardiovascular disease, and other
age-related disorders [1]. This apparent protection has gener-
ally been attributed to naturally-occurring antioxidant radical
scavengers, including K-tocopherol and carotenoids.
It is emerging that carotenoids have other biological e¡ects
besides radical scavenging, including antineoplastic and anti-
proliferative e¡ects on a variety of cell lines [2^6]. Prolifera-
tion of smooth muscle cells (SMC) plays a major role in the
alteration of the arterial wall in atherosclerosis [7^9]. Inhibi-
tion of SMC proliferation could be a mechanism by which
carotenoids might a¡ect progression of atherosclerosis.
The biological activities of the carotenoids are determined
by their diverse molecular structures [10]. We therefore tested
the main naturally-occurring dietary carotenoids, L-carotene,
L-cryptoxanthin, zeaxanthin, lutein and lycopene, as well as
canthaxanthin, which occurs in the edible mushroom Canthar-
ellus cinnabarinus and is a permissible food additive, for their
e¡ects on DNA synthesis in human aortic SMC.
2. Materials and methods
L-Carotene, canthaxanthin, zeaxanthin, lycopene, lutein and L-cryp-
toxanthin were gifts of Ho¡mann-La Roche (Basel, Switzerland).
Storage conditions and veri¢cation of purity (by HPLC and mass
spectrometry) were as described previously [11]. Tetrahydrofuran
(THF; HPLC grade) was obtained from Aldrich (Poole, Dorset,
UK), [methyl-3H]thymidine (88.7 Ci/mmol) from NEN (Hounslow,
Middx., UK), and [2,8-3H]adenine (24 Ci/mmol) from Amersham
(Aylesbury, Bucks., UK). 24-Well tissue culture plates were from Fal-
con (Becton Dickinson). All other chemicals were obtained from Sig-
ma (Poole, Dorset, UK). All chemicals were of the highest purity
available.
Human aortic SMC, from Clonetics Corporation (TCS Biologicals
Ltd., Buckingham, UK) at passage 3, were cultured in Dulbecco’s
modi¢ed Eagle medium (DMEM) supplemented with 20% heat-inac-
tivated foetal calf serum (FCS) (Life Technologies, Paisley, Scotland,
UK), 2 mM L-glutamine, 100 units/ml penicillin and 100 Wg/ml strep-
tomycin. Cells from passages 5^10 were used for experiments. Cells
were plated at 10 000 cells/cm2, i.e. 20 000 cells/well in 24-well tissue
culture plates, with 1 ml culture medium per well. Prior to prolifer-
ation studies these subcon£uent cells were rendered quiescent by par-
tially depriving them of serum. This was done by removing the me-
dium, washing the cells in the wells with PBS, and then replacing the
medium with DMEM containing 0.2% FCS, for 48 h prior to the start
of the proliferation experiment.
After the above 48 h serum deprivation period, the medium was
removed and the quiescent SMC in the wells were restimulated to
proliferate by re-exposing them to DMEM plus 20% FCS, with the
addition of [methyl-3H]thymidine (1 WCi/well), in the presence or ab-
sence of carotenoid, for 24 h. Carotenoid was added to the culture
medium in THF (0.5% v/v ¢nal concentration) at the same time as
[methyl-3H]thymidine and FCS. This is an established method of add-
ing carotenoids to cell cultures in a form available for cell uptake
[11,12]. Carotenoids were tested at ¢nal concentrations up to 23
WM, with stock solutions freshly made up for each experiment. For
incubations in the absence of carotenoid, THF (0.5% v/v) was added.
At the end of the 24 h restimulation period, the medium containing
unincorporated radiolabel was removed, the cells in the wells were
washed with phosphate-bu¡ered saline (PBS), ¢xed with methanol,
treated with 10% trichloroacetic acid, and digested with 0.2 M
NaOH [13]. The radioactivity in the digests was measured by liquid
scintillation counting [13].
Each experiment was repeated at least twice, and each frame of Fig. 1
(a^d) presents data from a representative experiment. Each data point
represents the mean of triplicate wells; error bars denote standard
error. Student’s t-test (unpaired) was used to compare [methyl-
3H]thymidine incorporation in carotenoid-treated cells with that of
control cells treated with THF vehicle (0.5% v/v), and to compare
cells treated with L-carotene with cells treated with other carotenoids.
Student’s t-test was carried out using SigmaPlot 3.0 software.
The e¡ect of carotenoids on proliferation of human aortic SMC
was also tested in selected cases by measuring the reduction of the
yellow, water-soluble dye 3-(4,5-dimethylthiazol-2-yl)-2,5-tetrazolium
bromide (MTT) to the dark blue insoluble formazan, as a result of the
cells’ dehydrogenase enzymes. The formazan is solubilised and the
absorbance value so obtained is thus a measure of the total number
of live cells in a culture. This well-established proliferation assay is
based on the method of Mosmann [14]. Proliferation experiments
were carried out as described above, except that [methyl-3H]thymidine
was omitted. As before, each treatment was performed in triplicate
wells. At the end of the 24 h restimulation period, MTT dye (0.5 mg/
ml ¢nal concentration) was added to the wells and the cells incubated
for a further 3 h (at 37‡C). The medium was removed and the in-
soluble formazan was solubilised in dimethylsulphoxide (200 Wl per
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well) and transferred to a 96-well £at-bottomed plate. The absorbance
was read at 570 nm, with background subtraction at 630 nm, using a
Dynatech MR5000 plate reader. Results are presented in Table 1.
Thiobarbituric acid-reactive substances (TBARS) were measured in
the medium, and in the cells, from SMC cultured as above in the
presence and absence of carotenoids. The TBARS assay was carried
out on the medium as described previously, with measurement of
absorbance at 532 nm [15]. TBARS in the SMC were measured by
a sensitive, £uorometric TBARS assay, adapted from that of Zhang
and colleagues [3]. Brie£y, the cells were scraped, treated with 1 ml of
0.08 N H2SO4 and 125 Wl of 10% (w/v) phosphotungstic acid. The
cells were centrifuged at 15 000Ug for 5 min, the supernatant was
discarded, and the cells resuspended in 500 Wl water. Thiobarbituric
acid and trichloroacetic acid were then added and the rest of the
processing carried out as described [15], except that the TBARS
were ¢nally extracted into 1 ml butanol, and the £uorescence read
at 553 nm, with excitation at 515 nm [3]. Measurements were made on
triplicate wells. TBARS concentrations were assessed as malondialde-
hyde (MDA) equivalents using a standard curve of 1,1,3,3-tetrame-
thoxypropane.
3. Results and discussion
L-Carotene inhibited DNA synthesis in SMC, in a concen-
tration-dependent fashion, as judged by incorporation of
[methyl-3H]thymidine (Fig. 1). These cells had been quies-
cence-synchronised by serum deprivation, veri¢ed by the es-
tablished technique of £ow cytometry with propidium iodide
staining [16], prior to restimulation with FCS in the presence
or absence of carotenoids. As well as inhibiting DNA syn-
thesis under these quiescence-restimulation conditions, L-car-
otene was also e¡ective at inhibiting DNA synthesis in SMC
which had not been initially rendered quiescent (data not
shown). Under the conditions used, we found no quenching
of scintillation counts by carotenoids, so this could not ex-
plain apparent decreases in [methyl-3H]thymidine incorpora-
tion.
The inhibition of DNA synthesis at these L-carotene con-
centrations was not due to toxicity of L-carotene. This was
established using a panel of well-established toxicity assays:
[3H]adenine leakage [15], trypan blue dye exclusion, and £uo-
rescein diacetate/propidium iodide dual staining measured by
£ow cytometry [17]. However, higher concentrations of L-car-
otene (47 WM) produced modest toxicity to SMC. The other
carotenoids were not toxic at concentrations up to 23 WM.
The THF vehicle (0.5% v/v) was non-toxic.
Canthaxanthin, tested up to 23 WM, was ine¡ective at in-
hibiting DNA synthesis ([methyl-3H]thymidine incorporation)
in SMC which were initially rendered quiescent by serum
deprivation then restimulated with FCS in the presence and
absence of carotenoids (Fig. 1a). L-Carotene, tested in the
same experiment, inhibited DNA synthesis (Fig. 1a). Zeaxan-
thin, tested under the same conditions, in a separate experi-
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Fig. 1. E¡ect of carotenoids on [methyl-3H]thymidine incorporation
in human aortic SMC. (a) L-Carotene (open circles) or canthaxan-
thin (¢lled circles), tested in parallel; (b) L-carotene (open circles) or
zeaxanthin (¢lled triangles), tested in parallel; (c) L-carotene (open
circles) or lycopene (¢lled squares), tested in parallel; (d) L-carotene
(open circles) or L-cryptoxanthin (¢lled, inverted triangles), tested in
parallel. Each data point represents the mean of triplicate wells;
bars denote standard errors. *P6 0.05, **P6 0.01, ***P6 0.001,
carotenoid signi¢cantly di¡erent from control (no carotenoid, THF
vehicle 0.5% v/v) by unpaired Student’s t-test. #P6 0.05, ##P6 0.01,
carotenoid signi¢cantly di¡erent from L-carotene by unpaired Stu-
dent’s t-test. For further details see Section 2.
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ment, gave concentration-dependent inhibition of DNA syn-
thesis, although it was not as potent as L-carotene, tested in
parallel (Fig. 1b). The experiments described were repeated
using the carotenoids lycopene, L-cryptoxanthin and lutein.
Lycopene showed stronger, concentration-dependent inhibi-
tion than L-carotene when tested alongside (Fig. 1c). L-Cryp-
toxanthin inhibited DNA synthesis, with a similar potency at
23 WM to L-carotene in the same experiment (Fig. 1d). Lutein
did not give signi¢cant inhibition of DNA synthesis (data not
shown). Hydroxyurea (1 mM), used as a positive control in
the above experiments, gave ca. 90% inhibition of DNA syn-
thesis. None of the carotenoids was mitogenic for SMC under
the conditions tested. Results of the MTT assay con¢rmed
that L-carotene and lycopene were able to inhibit proliferation
of human aortic SMC, and that lutein was ine¡ective (Table
1).
Possible mechanisms of the carotenoids’ e¡ects include in-
hibition of protein kinase C (PKC) activity, as reported for K-
tocopherol in inhibiting proliferation of SMC in vitro [18,19].
PKC is important in the signal transduction pathway leading
to cell proliferation and is a positive regulator in the transition
of SMC from quiescence to proliferation [20]. Inhibition of
proliferation might be linked to an antioxidant e¡ect, or to
formation of carotenoid products (e.g. epoxy-, peroxy- or hy-
droxy-derivatives) or metabolites (e.g. retinoids) in the cul-
tures. These mechanisms may not be mutually exclusive. Car-
otenoids may also a¡ect gene expression. For example, in
C3H/10T1/2 cells, carotenoids increased gap-junctional com-
munication by up-regulation of the connexin-43 gene, appa-
rently independently of the carotenoids’ provitamin A proper-
ties or antioxidant e¡ects [3,4]. In other examples, provitamin
A properties of L-carotene appear to play a role [5], although
this cannot explain the inhibition of DNA synthesis by lyco-
pene or zeaxanthin, which are non-provitamin A carotenoids,
in the present study. Another possible mechanism is that car-
otenoids might interfere with e¡ects of growth factors [6].
Antioxidant e¡ects of carotenoids could, in principle, be
involved in inhibition of proliferation, since lipid peroxides,
as well as oxidatively fragmented phospholipids and their en-
zymatic hydrolysis product lysophosphatidylcholine, are all
mitogenic for SMC [21,22]. Recently, we demonstrated that
L-carotene, canthaxanthin and zeaxanthin inhibited human
monocyte macrophage (HMM)-mediated LDL oxidation in
serum-free, iron-supplemented Ham’s F-10 medium [11].
Under the same conditions, lycopene, lutein and L-cryptoxan-
thin were weaker and more variable in their antioxidant ef-
fects (unpublished own results). Whilst SMC can oxidise LDL
under the same conditions as HMM [23], very little lipid per-
oxidation was evident in the present study, in which experi-
ments were performed in DMEM plus 20% FCS, in either the
supernatant medium or cells, in the absence or presence
of carotenoids, as judged by measurement of TBARS
(MDA90.25 nmol/ml of medium; MDA90.03 nmol per
20 000 cells). Similar values were obtained for control wells
devoid of cells, containing the same medium in the presence
and absence of carotenoids.
The order of potency, headed by lycopene, in the present
study does not appear to re£ect relative antioxidant potency
of carotenoids against LDL oxidation [11], or against 2,2P-
azobis(2,4-dimethylvaleronitrile) (AMVN)-induced oxidation
of liposomes [24]. Lycopene was, however, the most potent
of the common dietary carotenoids at scavenging the radical
cation of 2,2P-azinobis(3-ethylbenzothiolazine-6-sulphonate)
(ABTSc) [25], and at quenching singlet oxygen [26], and
although neither of these are likely to be directly relevant
here, they may illustrate the idea that the open-chain lycopene
might be more accessible to biologically active agents than the
other common carotenoids which possess cyclised end groups.
Also lycopene was more potent than L-carotene in several
other situations. These included protection of lymphocytes
from NO2 radical-mediated damage [27], inhibition of DNA
synthesis in MCF-7, Ishikawa and NCI-H226 cancer cell lines,
attributed to intervention with signal transduction mecha-
nisms of growth factors [6,28], and inhibition of cholesterol
synthesis in the macrophage-like cell line J-774A.1 [29]. This
last e¡ect might also have antiproliferative consequences. Any
of the above e¡ects might contribute to an inverse correlation
between carotenoids, especially lycopene, and atherosclerosis.
The striking inverse correlations between lycopene and can-
cers [30^33], which are more signi¢cant than for other caro-
tenoids [30^32], are consistent with the idea that lycopene
might be the most important dietary carotenoid in terms of
antiproliferative activity.
In the artery wall, proliferation of SMC gives rise to di¡use
intimal thickening, as well as to ¢brous cap formation in
progressing atherosclerotic lesions. The latter may have a pro-
tective role in advanced atherosclerosis, as advanced lesions
with thicker ¢brous caps are less likely to rupture [34]. The
formation of the ¢brous cap occurs during the transition from
fatty streak (early lesion) to intermediate lesion. In the very
early stages of atherosclerosis, di¡use intimal thickening may
provide the ‘seedbed’ for subsequent lesion formation. Caro-
tenoids might play a part in inhibiting these various manifes-
tations of SMC proliferation.
Our results are consistent with the inverse epidemiological
association between dietary carotenoids and incidence of is-
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Table 1
E¡ect of carotenoids, tested in parallel, on proliferation of human aortic SMC, determined by measuring the reduction of MTT to formazan
(absorbance at 570 nm, with background subtraction at 630 nm)
Addition Concentration n Mean formazan absorbance Standard error P
THF vehicle 0.5% (v/v) 3 0.530 0.057 ^
L-Carotene 4.7 WM 3 0.383 0.061 0.152
L-Carotene 23.3 WM 3 0.354 0.021 0.044
Lutein 4.7 WM 3 0.556 0.056 0.763
Lutein 23.3 WM 3 0.494 0.017 0.574
Lycopene 4.7 WM 3 0.352 0.013 0.038
Lycopene 23.3 WM 3 0.385 0.017 0.071
P values were obtained using Student’s t-test (unpaired) to compare the formazan absorbance values in the presence of carotenoids with those of
the THF vehicle control. For further details see Section 2.
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chaemic heart disease [1]. Although carotenoids possess anti-
oxidant activity, the contribution of this to the carotenoids’
apparent protective e¡ects has been questioned [35], and anti-
proliferative e¡ects of carotenoids may be more important in
vivo. The prepotency of lycopene in the present study is con-
sistent with the apparently bene¢cial e¡ect of ‘Mediterranean’
diets in this context, since tomatoes, the main food source of
lycopene, are an abundant component of such diets.
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